Finance

Beta
Lists
GPCR:NASDAQ
Structure Therapeutics Inc
$37.58
-3.79%
(-1.48) 1D
$37.58
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GPCR...
Open
$38.71
High
$39.82
Low
$37.39
Mkt. cap
2.67B
Avg. vol.
760.60K
Volume
520.86K
52-wk high
$94.90
52-wk low
$15.80
EPS
-$2.72
Beta
-1.43
Shares outstanding
71.07M
No. of employees
233
Open
$38.71
High
$39.82
Low
$37.39
Mkt. cap
2.67B
Avg. vol.
760.60K
Volume
520.86K
52-wk high
$94.90
52-wk low
$15.80
EPS
-$2.72
Beta
-1.43
Shares outstanding
71.07M
No. of employees
233
Analyst outlook
Analyst Ratings
Based on 10 analysts giving stock ratings to GPCR in the past 3 months
Strong Buy
Buy
10
Hold
0
Sell
0
12 month forecast
Based on 10 Wall Street analysts offering 12 month price targets for GPCR in the last 3 months.
Highest
Current $37.58
$145.00 (+285.84%)
Average
$111.50 (+196.70%)
Lowest
$100.00 (+166.10%)
News stories
From sources across the web
About Structure Therapeutics Inc
CEO-
Employees233
Founded2016
HeadquartersSouth San Francisco, California, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
42.87M
54.71M
58.99M
68.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.44M
15.74M
14.80M
17.57M
Operating expense
56.31M
70.45M
73.79M
-13.74M
Total operating expenses
56.31M
70.45M
73.79M
-13.74M
Operating income
-56.31M
-70.45M
-73.79M
13.74M
Other non operating income
-
-
-
-13.86M
EBT including unusual items
-46.74M
-61.52M
-65.60M
33.17M
EBT excluding unusual items
-46.74M
-61.52M
-65.60M
35.75M
Income tax expense
98.00K
139.00K
108.00K
170.00K
Effective tax rate
-0.21%
-0.23%
-0.16%
0.51%
Other operating expenses
-
-
-
-100.00M
Net income
-46.83M
-61.66M
-65.71M
33.00M
Net profit margin
-
-
-
-
Earnings per share
-0.27
-0.36
-0.37
-0.46
Interest and investment income
9.58M
8.93M
8.18M
35.87M
Interest expense
-
-
-
-
Net interest expenses
9.58M
8.93M
8.18M
35.87M
Depreciation and amortization charges
-
-
-
-
EBITDA
-56.04M
-70.16M
-73.41M
14.47M
Gain or loss from assets sale
-
-
-
-10.25M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more